PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8873220-0	1996	The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism.	Tolbutamide	53-64	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	16-22	
8873220-11	1996	Studies in a recombinant yeast expression system showed that the Leu359 variant had the highest Km and the lowest Vmac for hydroxylation of tolbutamide of all the CYP2C9 allelic variants.	Tolbutamide	140-151	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	163-169	
8873220-13	1996	The present data suggest that the incidence of the Leu359 allelic variant of CYP2C9 may account for the occurrence of poor metabolizers of tolbutamide.	Tolbutamide	139-150	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	77-83